How to appeal an Aetna adult adhd medications denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Aetna-specific note: Owned by CVS Health since 2018. CVS Caremark is the PBM. Aetna ASA administers self-funded ERISA plans. Meritain Health is Aetna's TPA brand.

What Aetna's policy requires for adult adhd medications

Cited policy: Aetna Clinical Policy Bulletin — Attention Deficit/Hyperactivity Disorder (ADHD)

PA for branded stimulants. Step therapy from generic. CPB 0426 explicitly considers adult ADHD diagnosis 'medically necessary' when DSM criteria met. Quantity limits per label.

How Aetna denies adult adhd medications — and how to counter it

Where Aetna pushes back: 1) 'Insufficient documentation of childhood symptoms' — collateral history demanded; 2) Step therapy: must fail two generic stimulants before brand; 3) Concurrent stimulant + non-stimulant combination denied.

Counter-arguments that hold up: Quote CPB 0426 — itself permits adult diagnosis when DSM met. DSM-5-TR explicitly permits retrospective recall of childhood symptoms; collateral preferred but NOT required. Combination therapy supported in CADDRA + APA frameworks for partial responders.

What Aetna typically denies for adult adhd medications

Across Aetna's commercial and Medicare books, denials cluster around a small number of patterns. For adult adhd medications, expect:

• UM-2575 medical necessity denials
• Prior auth absent
• Step therapy on specialty drugs
• Out-of-network ER reduction

Treatments most often denied in this category

These are the adult adhd medications treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Vyvanse
• Adderall XR
• Concerta
• Focalin XR
• Ritalin LA
• Strattera

How to submit the appeal to Aetna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Aetna cited in the denial.
3. File the appeal through Aetna's portal (members: https://www.aetna.com ; providers: https://www.aetnaprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Aetna's prior-authorization criteria by drug: Aetna PA criteria on ApprovalHelp.